Tagraxofusp

ELZONRIS 1 mg/ml, oplossing voor infusie

Oplossing voor infusieNetherlandsAuthorisedAuthorised 2 Feb 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ElzonrisEuropean UnionAuthorised

Elzonris 1 MG/ML Concentrado Para Solucion Para PerfusionSpain · 1 mg/ml · concentrado para solución para perfusión · Stemline Therapeutics B.V.Same brand
ElzonrisEuropean Union · Stemline Therapeutics B.V.Same brand
ElzonrisCroatiaSame brand
ElzonrisItaly · Concentrato per soluzione per infusione · Stemline Therapeutics BVSame brand
Elzonris Concentrate for Solution for Infusion 1000 MCG/MLSingapore · 1.0 MG/mL · infusion, solution concentrate · A. Menarini Singapore Pte. LTD.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tagraxofusp

ELZONRIS 1 mg/ml, oplossing voor infusie

Oplossing voor infusieNetherlandsAuthorisedAuthorised 2 Feb 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ElzonrisEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ElzonrisUnited States · 1000MCG · solution · Stemline Therapeutics INC

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tagraxofusp
Dosage form: Oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 2 Feb 2021
Registration: EU/1/20/1504
Marketing authorisation holder: TMC Pharma (EU) Limited
ATC code: L01XX67
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005031
EU number: EU/1/20/1504